FOLFOX 6
Showing 1 - 25 of >10,000
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in
Active, not recruiting
- Adenocarcinoma of the Esophagus
- +5 more
- oxaliplatin
- +6 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022
Neurotoxicity in Gastrointestinal Cancer Patients Receiving
Recruiting
- Gastrointestinal Cancer
- Folfox Protocol
-
Cairo, Abassia, EgyptAin shams university
Aug 8, 2022
Colo-rectal Cancer, Neuropathy;Peripheral, Mucositis Trial in Tanta (Pentoxifylline, Placebo, FOLFOX-6 regimen)
Enrolling by invitation
- Colo-rectal Cancer
- +2 more
- Pentoxifylline
- +2 more
-
Tanta, Gharbyia, EgyptTanta University
Oct 18, 2022
Colorectal Cancer Trial in Paris (FOLFOX regimen, fluorouracil, leucovorin calcium)
Active, not recruiting
- Colorectal Cancer
- FOLFOX regimen
- +5 more
-
Paris, FranceGERCOR Groupe Cooperateur Multidisciplinaire en Oncologie
Jan 20, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- metformin hydrochloride
- +4 more
-
Cleveland, Ohio
- +1 more
Aug 9, 2021
Metastatic Colorectal Cancer Trial in Shanghai (Fruquintinib, FOLFIRI, mFOLFOX6)
Not yet recruiting
- Metastatic Colorectal Cancer
- Fruquintinib
- +2 more
-
Shanghai, Shanghai, ChinaDepartment of Colorectal Surgery Fudan University Shanghai Caner
Nov 23, 2022
Colorectal Cancer, Cancer of Pancreas, Pancreatic Tumor Trial in Detroit (FOLFOX6, EGFRBi armed ATC Infusions)
Completed
- Colorectal Cancer
- +7 more
- FOLFOX6
- EGFRBi armed ATC Infusions
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 30, 2022
Unresectable Adenocarcinoma of the Esophagus, Metastatic Adenocarcinoma of the Esophagus, Unresectable Adenocarcinoma of Gastric
Completed
- Unresectable Adenocarcinoma of the Esophagus
- +3 more
- FOLFOX
- +2 more
-
Los Angeles, California
- +1 more
Sep 3, 2021
Gastric Cancer Trial in Wuhan (DC, concurrent chemoradiotherapy with 5-FU/CF, radiation)
Recruiting
- Gastric Cancer
- DC
- +2 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jan 29, 2022
Colorectal Cancer Metastatic, Liver Metastasis Colon Cancer Trial in Spain (FOLFOX regimen, Anti-EGFR or Bevacizumab,
Recruiting
- Colorectal Cancer Metastatic
- Liver Metastasis Colon Cancer
- FOLFOX regimen
- +2 more
-
Sabadell, Barcelona, Spain
- +7 more
Jan 7, 2022
Colon Cancer With Metastases to the Liver Trial in Argentina, United States (LC beads loaded with Irinotecan, Oxaliplatin,
Completed
- Colon Cancer With Metastases to the Liver
- LC beads loaded with Irinotecan
- +4 more
-
Huntsville, Alabama
- +9 more
Jun 9, 2021
Gastric Carcinoma Stage IV, Esophagogastric Junction Adenocarcinoma Stage IV Trial in Moscow (Irinotecan, Oxaliplatin, 5-FU)
Recruiting
- Gastric Carcinoma Stage IV
- Esophagogastric Junction Adenocarcinoma Stage IV
- Irinotecan
- +3 more
-
Moscow, Russian FederationBlokhin's Russian Cancer Research Center
Apr 11, 2021
HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer Trial in Seoul (HERZUMA+mFOLFOX)
Recruiting
- HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
-
Seoul, Korea, Republic ofDivision of Medical Oncology, Yonsei Cancer Center, Yonsei Univ.
Jan 19, 2021
Rectal Cancer Trial in United States (radiation, drug, procedure)
Active, not recruiting
- Rectal Cancer
- Endo-HDR (if randomized to this arm)
- +4 more
-
Tampa, Florida
- +3 more
Nov 1, 2021
Neuropathy, Painful, Chemo-induced Peripheral Neuropathy, Colorectal Cancer Trial in Saint Louis (Lidocaine Hydrochloride,
Completed
- Neuropathy, Painful
- +2 more
- Lidocaine Hydrochloride
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine/Barnes Jewish Hospital
Feb 10, 2022
Rectal Cancer Trial in Korea, Republic of (radiation, drug, procedure)
Recruiting
- Rectal Cancer
- short-course radiotherapy
- +3 more
-
Daegu, Korea, Republic of
- +8 more
Jan 8, 2023
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8
- +5 more
- Biospecimen Collection
- +9 more
-
Scottsdale, Arizona
- +2 more
Oct 11, 2023
Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus
Terminated
- Advanced Gastrointestinal (GI) Malignancies
- +3 more
- ADI-PEG 20 plus modified FOLFOX6
-
San Francisco, California
- +34 more
Apr 18, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Not yet recruiting
- Metastatic Colon Adenocarcinoma
- +6 more
- Balstilimab
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 17, 2022
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial
Not yet recruiting
- Advanced Esophageal Adenocarcinoma
- +14 more
- Fluorouracil
- +8 more
- (no location specified)
Jan 3, 2023
Operable T2-3N+M0 Rectal Cancer (Stage III) Trial in Canada (FOLFOX, high dose rate endorectal brachytherapy)
Active, not recruiting
- Operable T2-3N+M0 Rectal Cancer (Stage III)
- FOLFOX
- high dose rate endorectal brachytherapy
-
Gatineau, Quebec, Canada
- +7 more
May 13, 2021
Rectal Cancer, Cancer of the Rectum, Colorectal Cancer Trial in United States (5-Fluorouracil, Bevacizumab, Radiation Therapy)
Colorectal Cancer Trial in Canada (Folfox plus Bevacizumab and reolysin, Folfox plus Bevacizumab)
Completed
- Colorectal Cancer
- Folfox plus Bevacizumab and reolysin
- Folfox plus Bevacizumab
-
Calgary, Alberta, Canada
- +9 more
Mar 26, 2020